Bernard Refouvelet

5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease

David Pertuit, Brice Moulari, Thomas Betz et al. · Journal of Controlled Release · 2007 · 121 citations

Nanoparticles, Nanomedicine, Engineering +6

The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators

Mohamed Benchekroun, Alejandro Romero, Javier Egea et al. · Journal of Medicinal Chemistry · 2016 · 101 citations · Full text

Tacrine Derivatives, Lipid Peroxidation, Redox Biology +17

Synthesis and antioxidant activity evaluation of new hexahydropyrimido[5,4-c]quinoline-2,5-diones and 2-thioxohexahydropyrimido[5,4-c]quinoline-5-ones obtained by Biginelli reaction in two steps

Lhassane Ismaïli, Arulraj Nadaradjane, Laurent Nicod et al. · European Journal of Medicinal Chemistry · 2007 · 86 citations

Antioxidant Activity Evaluation, Biginelli Reaction, Biochemistry +5

Novel Tacrine‐Grafted Ugi Adducts as Multipotent Anti‐Alzheimer Drugs: A Synthetic Renewal in Tacrine–Ferulic Acid Hybrids

Mohamed Benchekroun, Manuela Bartolini, Javier Egea et al. · ChemMedChem · 2014 · 72 citations

Quinolone–benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer Disease

Marc Pudlo, Vincent Luzet, Lhassane Ismaïli et al. · Bioorganic & Medicinal Chemistry · 2014 · 72 citations · Full text

Molecular Pharmacology, Neurodegenerative Diseases, Antioxidant Hybrids +11